Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Daiichinkyo Co's Marketable Securities for the quarter that ended in Jun. 2026 was MXN3,530 Mil.
Daiichinkyo Co's annual Marketable Securities
declined
from Mar. 2024 (MXN63,922 Mil) to Mar. 2025 (MXN11,102 Mil) but then
increased
from Mar. 2025 (MXN11,102 Mil) to Mar. 2026 (MXN11,902 Mil).
Daiichinkyo Co (MEX:4568N) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Daiichinkyo Co Marketable Securities Related Terms
Daiichinkyo Co Marketable Securities Historical Data
* Premium members only.
The historical data trend for Daiichinkyo Co's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Marketable Securities of MXN3,530 Mil mean?
Daiichinkyo Co (MEX:4568N) has a Marketable Securities of MXN3,530 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Daiichinkyo Co and its competitors.
Is Daiichinkyo Co's Marketable Securities too high?
Daiichinkyo Co's current Marketable Securities is MXN3,530 Mil. Overall, Daiichinkyo Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Marketable Securities compare to LLY and JNJ?
Daiichinkyo Co's Marketable Securities of MXN3,530 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Daiichinkyo Co and its competitors. Daiichinkyo Co's current Marketable Securities is MXN3,530 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Daiichinkyo Co (MEX:4568N) has a current Marketable Securities of MXN3,530 Mil. The stock's GF Value™ is MXN602.55, compared to a current price of MXN286.67 — trading 52.4% below its estimated fair value. The current Marketable Securities is MXN3,530 Mil. Daiichinkyo Co's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Daiichinkyo Co (MEX:4568N), the current Marketable Securities is MXN3,530 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiichinkyo Co (MEX:4568N) Overvalued in 2026?
Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued.
The current stock price of MXN286.67 is trading 52.4% below its estimated GF Value™ of MXN602.55.
Key valuation signals for MEX:4568N:
Marketable Securities: MXN3,530 Mil
GF Value™: MXN602.55 vs. price of MXN286.67 (52.4% below fair value)
No single metric tells the full story. See the MEX:4568N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
79GF Score
Get the complete analysis for MEX:4568N
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4568N has been successfully added to your 
